News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Awards & Honors: May 2025

three white trophies behind a red background

Dr. Fabrizio Michelassi, chair of the Department of Surgery, has been named president-elect of the American Surgical Association. Founded in 1880, the association is the nation’s oldest and most prestigious surgical organization. Its members include the nation’s most prominent surgeons from the country's leading academic medical institutions.

Dr. Chibuikem Ikwuegbuenyi, research associate in neurological surgery, was awarded the Charles Tator Spinal Cord Injury Resident Research Award by the American Association of Neurological Surgeons. His work was recognized as the highest-rated abstract in spinal cord injury research submitted by a trainee. 

Dr. Aryeh Zolin, resident in the Department of Neurology, was named a 2025 Leon Levy Scholar in Neuroscience by the New York Academy of Sciences and the Leon Levy Foundation. The initiative supports early-career scientists conducting pioneering neuroscience research throughout New York City. Dr. Zolin was recognized for his work examining how the pathology that drives neurodegeneration in Parkinson’s disease is transmitted between neurons and spreads through neural circuits.

Two WCM Scientists Receive Inaugural Pershing Square Foundation Ovarian Cancer Challenge Grant

blue spherical objects against a black backdrop

Dr. Juan R. Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology, and Dr. David Lyden, the Stavros S. Niarchos Professor in Pediatric Cardiology, both from Weill Cornell Medicine, have been named inaugural recipients of the Pershing Square Foundation’s 2025 Ovarian Cancer Challenge Grant.

The challenge grant provides $750,000 in funding over three years to support innovative research into ovarian cancer that may advance the biological understanding of the disease, as well as its detection, prevention and treatment. The American Cancer Society estimates that ovarian cancer claims nearly 13,000 lives annually, making it one of the leading causes of cancer deaths among women.

New Insights into Bladder Cancer Treatment Could Help Improve Immunotherapies

Green-gloved hand holding vial of BCG

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat early-stage bladder cancer.

Now, a team of researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) is expanding the understanding of how the treatment works — an understanding that could help improve the effectiveness of immunotherapies more broadly.

Dr. Michael Glickman

Dr. Michael Glickman